✨ Your Portfolio is fetched and updated from zerodha.
Small Miscellaneous
Market Cap
₹5,833 Cr.
P/E
64.74
About
Entero Healthcare Solutions Limited is a rapidly growing healthcare products distribution platform in India, offering demand generation and fulfilment services to manufacturers. It promotes product br… Read more
Entero Healthcare Solutions Limited is a rapidly growing healthcare products distribution plat… Read more
Low
991
52W Range
High
1583
  • Entero Healthcare
  • Royal Sense
  • Jeena Sikho Life

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison
FAQs on Entero Healthcare Solutions Ltd. Business

Entero Healthcare Solutions Limited is one of India's largest and fastest growing healthcare products distribution platforms. The company offers both demand generation and demand fulfilment solutions to healthcare product manufacturers. It offers demand generation solutions to healthcare product manufacturers by promoting and creating awareness of their product brands to healthcare professionals, doctors and channels such as pharmacies, hospitals (both private and government), clinics and customers through e-commerce marketplaces. Further, it provides end-to-end healthcare products distribution solutions including imports, central warehousing, redistribution, last mile delivery and connection with the pharmacies, hospitals and clinics.

Entero Healthcare major competitors are Royal Sense, Jeena Sikho Life, Elitecon Internation, Lloyds Enterprises, Honasa Consumer, Optiemus Infracom, SG Mart.
Market Cap of Entero Healthcare is ₹5,873 Crs.
While the median market cap of its peers are ₹4,994 Crs.

Entero Healthcare seems to be less financially stable compared to its competitors.
Altman Z score of Entero Healthcare is 8.6 and is ranked 6 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Mar Jun Sep Dec Dec
Conference Call Mar Jun Sep Dec Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
[]
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material